Latest filing published 15 Jun 2016 for PALVELLA THERAPEUTICS, INC., €3,102.
Insider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +151.8%Entry US$136.00 · Close at T+365 US$342.40
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Louis Matis: trading record in brief
This profile gathers the share dealings of Louis Matis in Palvella Therapeutics, Inc. Between 13 June 2016 and 14 June 2016, the trades on record add up to 2 filings.
On the market, this insider has only ever bought: 2 purchases, €15k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The record was last updated on 15 June 2016 with an open-market purchase (€3,102) in Palvella Therapeutics, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Louis Matis
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,085 shares@ US$1.6820.4% of flowCommon StockSEC:0000899243-16-022948:0Canonical exit: 11 Sept 2016 (T+90)
- 7,915 shares@ US$1.7179.6% of flowCommon StockSEC:0000899243-16-022948:1Canonical exit: 12 Sept 2016 (T+90)
2 of 2 declarations
